Source Flunixin Meglumine Injection for Poultry, Livestock, and Disease Prevention

Strategic Sourcing Guide for Flunixin Meglumine Injection

Procuring veterinary pharmaceuticals requires a disciplined approach that balances technical efficacy with rigorous supply chain verification. For buyers targeting Flunixin Meglumine Injection, the market presents a complex landscape of formulations, packaging standards, and regulatory requirements. This guide synthesizes observed market data and technical attributes to provide a framework for evaluating potential suppliers and ensuring product integrity. The focus remains on evidence-based criteria, avoiding unverified claims while highlighting the specific parameters that define a reliable procurement strategy for this class of non-steroidal anti-inflammatory drugs (NSAIDs).

Technical Specifications and Formulation Variability

The technical profile of Flunixin Meglumine Injection is defined by its active ingredient and physical characteristics. The primary component is consistently identified as Flunixin Meglumine, a chemical synthetic drug designed for veterinary use. However, buyers must recognize that the market exhibits significant variability in physical form and concentration, which directly impacts administration and storage.

Observed product attributes indicate that the liquid form typically presents as a clear liquid ranging from colorless, though some listings describe a white appearance, potentially indicating different formulations or suspended states. The product is available in various container sizes, with specific standards noting volumes of 10ml, 50ml, and 100ml. Some specifications also reference 250ml options, suggesting a range suitable for both individual animal treatment and herd-level administration.

The packaging configuration is equally diverse. While bottles are a standard unit, they are frequently enclosed in carton boxes or OEM boxes. Standardized packaging often follows a 10ml*10/box configuration, but OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) options allow for custom packaging requests. Buyers should verify that the physical description of the received goods matches the ordered specification, as discrepancies in appearance or volume can indicate batch inconsistencies or storage issues.

Regulatory Compliance and Certification Standards

In the veterinary pharmaceutical sector, certification serves as a primary indicator of manufacturing quality and regulatory adherence. The supply chain for Flunixin Meglumine Injection frequently references ISO certification as a baseline standard for quality management systems. While this certification is a positive signal, it should be treated as a verification point rather than a guarantee of specific product efficacy.

Buyers must scrutinize the Manufacturer details. The market data identifies Loongnucleus Co.,Ltd. as a known entity within this supply chain, originating from China. When evaluating potential suppliers, the origin country is a critical factor for logistics and regulatory compliance. Products originating from China must be cross-referenced with the importing country's veterinary drug authority requirements.

Furthermore, the Type of product is classified as The First Class in some contexts, which may imply a specific tier of quality or regulatory status within the domestic market of origin. However, international buyers must not assume this classification automatically translates to their local regulatory framework. The Validity Period is consistently noted as Two Years, a critical metric for inventory planning and shelf-life management. Buyers should request batch-specific expiration dates rather than relying solely on the general two-year standard, as storage conditions can impact actual product longevity.

Cost Drivers and Economic Parameters

The economic landscape for Flunixin Meglumine Injection is characterized by a wide range of pricing and minimum order quantities (MOQ). The observed price range in the market spans from 0.5 to 5 USD per unit, though this figure likely represents a per-unit cost that varies significantly based on volume, packaging, and customization. This wide variance suggests that price alone is an unreliable metric for quality assessment.

MOQs are equally flexible, ranging from 1 unit to 10,000 units. This flexibility accommodates both small veterinary clinics and large-scale agricultural operations. However, some suppliers indicate that the MOQ should be discussed in person, implying that the listed ranges are indicative rather than fixed. This negotiation phase is crucial for buyers to understand the cost implications of different order sizes.

The Varieties of the product also influence cost. The market lists General Disease Prevention Medicine, Growth Promoting Medicine, and Parasite Disease Prevention Medicine under the same core keyword umbrella. Buyers must ensure they are sourcing the specific variety required for their intended use, as formulations for disease prevention may differ in cost and regulatory status from those marketed for growth promotion. Additionally, the availability of OEM and custom packaging services introduces variable costs that must be factored into the total procurement budget.

Typical Applications and Pharmacodynamic Factors

Understanding the pharmacodynamic profile of Flunixin Meglumine is essential for selecting the correct product for specific animal classifications. The product is applicable to Poultry and Livestock, covering a broad spectrum of animal health care needs. The Main Function extends to Internal and External Deworming in some contexts, although Flunixin Meglumine is primarily known for its anti-inflammatory and analgesic properties. This discrepancy highlights the need for buyers to verify the specific indication for each product listing.

The efficacy of the drug is influenced by several Pharmacodynamic Influential Factors. These include Animal Species, Combined Medication, Repeated Medication, and Incompatibility. Buyers must consult veterinary professionals to ensure that the Flunixin Meglumine Injection is compatible with other medications the animals may be receiving. The factor of Repeated Medication suggests that dosing frequency and cumulative effects are critical considerations in the treatment protocol.

Additionally, the product is categorized under Vitamins, Minerals, Amino Acids in some listings, which may indicate a multi-component formulation or a specific marketing classification. This classification requires careful verification to ensure the product delivers the intended therapeutic effect without unnecessary additives that could interfere with the primary active ingredient.

Supplier Evaluation and Manufacturing Capabilities

Evaluating suppliers for Flunixin Meglumine Injection requires a focus on their manufacturing capabilities and customization options. The market data confirms that Customization is Available, allowing buyers to tailor products to specific regional or operational needs. This includes OEM Bottles, OEM Boxes, and Custom Make as Requests for packaging.

When assessing a supplier, buyers should verify their capacity to handle OEM and ODM orders. The presence of Packaging: OEM&ODM suggests a flexible manufacturing environment. However, flexibility should not come at the expense of quality control. Buyers must ensure that the supplier maintains strict adherence to the prod_standard specifications, such as the 100ml/box or 10ml/bottle configurations.

The Manufacturer identity is a key evaluation point. While Loongnucleus Co.,Ltd. is a documented manufacturer, buyers should not limit their search to a single entity. Instead, they should verify the credentials of any potential supplier, ensuring they have the necessary infrastructure to produce Chemical Synthetic Drugs that meet international standards. The Shape of the product is noted as Powder in some contexts, which may refer to the raw material or a specific formulation type, requiring clarification to ensure the final product is the intended injection.

Quality Control and Storage Protocols

Maintaining product integrity from the point of manufacture to the point of administration is paramount. The Storage Method for Flunixin Meglumine Injection is strictly defined as Light Proof or Store in a Light-Proof environment. This requirement is critical because exposure to light can degrade the active ingredient, reducing efficacy and potentially creating harmful byproducts.

The Storage Type is further specified as a Dry and Cool Place. This dual requirement ensures that the product remains stable under conditions that prevent hydrolysis and thermal degradation. Buyers must verify that their logistics partners and storage facilities can meet these stringent conditions. Failure to maintain the correct storage environment can invalidate the Two Years validity period and compromise the safety of the medication.

Quality control also extends to the Appearance of the product. The standard description of a Clear Liquid Ranging From Colorless serves as a visual quality control check. Any deviation from this appearance, such as cloudiness or discoloration, should trigger an immediate rejection of the batch. The Component is listed as Animal in some contexts, which may refer to the source of certain excipients or a specific classification, requiring verification to ensure no allergens or contraindications exist for the target animal species.

Long-Term Procurement Considerations

Sourcing Flunixin Meglumine Injection is not a one-time transaction but a long-term strategic relationship. Buyers must consider the Products portfolio of the supplier, which includes All Arrange of Animal Health Care. A supplier with a comprehensive portfolio may offer better support, consistent quality, and the ability to source complementary products like Growth Promoting Medicine or Parasite Disease Prevention Medicine from a single source.

The Main Ingredients and Standard specifications must remain consistent over time to ensure treatment protocols are not disrupted. Any changes in the formulation or packaging should be communicated well in advance. The MOQ flexibility allows for scaling operations, but buyers should negotiate terms that allow for adjustments based on seasonal demand or herd size fluctuations.

Finally, the Certification status, such as ISO, should be monitored for renewal and compliance. A lapse in certification could indicate a lapse in quality management systems. Buyers should establish a protocol for periodic audits or requests for updated certification documents to ensure the supply chain remains robust and compliant with evolving regulatory standards. By focusing on these long-term factors, buyers can secure a reliable supply of Flunixin Meglumine Injection that supports the health and productivity of their livestock and poultry operations.